Market header image

Bulletins

You are here

2016-0819 - Suspension - Pivotal Therapeutics Inc. (PVO)

August 17, 2016

Pivotal Therapeutics Inc. is in default of CSE requirements. Effective at market close, Pivotal Therapeutics, currently the subject of a Cease Trade Order, will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.

Date: Effective market close, August 17, 2016
Symbol: PVO

If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com



CSE Listing(s):

Advertisement

Publicité

Latest CSE News

Upcoming Events

image_2.png

The Impact of the Pandemic on Women's Advancement during Recovery

Tuesday, September 29, 2020 -
12:00pm to 1:00pm
2020-09-29-Tech-Tuesdays-Best-of-Summer_Website.jpg

Tech Tuesdays

Tuesday, September 29, 2020 -
4:15pm to 5:00pm
2020-09-30-The-Psychedelics-Renaissance_Website.png

The Psychedelics Renaissance

Wednesday, September 30, 2020 -
1:00pm to 3:00pm

Advertisement

Publicité